Top compounds associated with response to LRRC9


Feature Type Standardized
Nominal ANOVA
mRNA simvastatin CTRPv2 pan-cancer AAC -0.034 0.4
mRNA BRD-K27188169 CTRPv2 pan-cancer AAC -0.045 0.4
mRNA LY-2157299 CTRPv2 pan-cancer AAC -0.064 0.4
mRNA ML162 CTRPv2 pan-cancer AAC 0.028 0.4
mRNA Mdivi-1 CTRPv2 pan-cancer AAC 0.031 0.4
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.03 0.4
mRNA ML050 CTRPv2 pan-cancer AAC 0.031 0.4
mRNA GDC-0941 gCSI pan-cancer AAC -0.049 0.4
mRNA lapatinib CTRPv2 pan-cancer AAC -0.029 0.4
mRNA nintedanib CTRPv2 pan-cancer AAC 0.03 0.4
Download CSV